Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022
Isabel Bergeri(World Health Organization), Brianna Cheng(University of Toronto), Hannah C. Lewis(World Health Organization), Joseph Okeibunor(World Health Organization Regional Office for Africa), Tasnim Azim(International Centre for Diarrhoeal Disease Research), Lubna Al Ariqi(World Health Organization Regional Office for the Eastern Mediterranean), David L. Buckeridge(McGill University), Marta Valenciano(World Health Organization), Mairead Whelan(University of Calgary), Matthew P. Cheng(McGill University Health Centre), Niklas Bobrovitz(University of Calgary), Xiaomeng Ma(University of Toronto), Aisling Vaughan(World Health Organization Regional Office for Europe), David A. Clifton(University of Oxford), Mercedes Yanes‐Lane(McGill University), Andrea Vicari(World Health Organization Regional Office for the Americas), Christian Cao(University of Calgary), Anthony Nardone(World Health Organization), Tingting Yan(University of Toronto), Linh‐Vi Le(World Health Organization Regional Office for the Western Pacific), Pushpa Ranjan Wijesinghe(World Health Organization Regional Office for South-East Asia), Jesse Papenburg(McGill University Health Centre), Maria D. Van Kerkhove(World Health Organization), Arash Rashidian(Tehran University of Medical Sciences), Lorenzo Subissi(World Health Organization - Pakistan), Richard Pebody(World Health Organization Regional Office for Europe), Rahul K. Arora(University of Calgary), Zihan Li(University of Calgary)
Cited by 42
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|714
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
|The Lancet Infectious Diseases|2023|658
One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities
|Proceedings of the National Academy of Sciences|2014|643
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548